ENOV (DJO Global) Market Value to Book Value Ratio

DJO Global - graphic logo of issuer ENOV

The daily price action for Enovis Corporation (ENOV) illustrated below reflects the dynamics of a company attracting leading engineers to develop advanced prosthetics, where the indicator stands at 0.88. The business relies on the mass production of titanium products, which ensures excellent profitability despite high R&D costs. Production stability is maintained through a broad network of counterparties and the availability of backup inventories of essential components.

Enovis Inc. (ENOV) Market Capitalization to Net Assets: for the period 04/28/2023 - 10/30/2026

Analytical breakdowns and data insights for company Enovis Corp (ENOV)

- share price and consensus valuation forecast:
Stock Quotes Enovis Corporation|ENOV - Price Target Chart
- business market valuation indicators:
Market Value DJO Global|ENOV - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Enovis|ENOV - Net Asset Value|Market Capitalization to Book Value Ratio enovis.com|ENOV - Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Enovis Corporation|ENOV - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital DJO Global|ENOV - Company Total Debt Obligations|Debts to Book Capitalization DJO Global|ENOV - Company Long-Term Debts|Company Short-Term Debt Enovis|Quick Ratio enovis.com
- earnings and market multiples details:
ENOV - Net Financial Result
Analysis of all company metrics:Enovis Corporation - ENOV
Flagship merchandise of Enovis Corp

The selection of high-quality issuers is based on a multiples analysis, where the ratio of market value to equity reveals the extent of asset overvaluation relative to their book value. This market cap to book value ratio reflects the premium for the intangible advantages of Enovis Corporation (ENOV), including patent protection and surgeon loyalty, allowing the investor to assess the fundamental balance of the business through this chart.

Competitor analysis

BSX (Boston Scientific) - Market Cap to Net Assets Ratio|EW (edwards.com) - Market Value to Book Value Ratio|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|IART - Market Capitalization to Book Value|ESTA (Establishment Labs) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio betabionics.com|Market Value to Book Value Ratio IRADIMED (IRMD)|Market Value to Book Value Ratio EMBC (Embecta Corp)|Market Capitalization to Book Value Ratio TNDM (Tandem Diabetes)|Market Capitalization to Book Value Axogen Surgical (AXGN)|SIBN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets OFIX|BVS: Market Capitalization to Book Value Ratio|Market-to-Book Ratio OrthoPediatrics (KIDS)|TMCI (Treace Medical) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio SRTA (Strata Medical)|Market Cap to Net Assets Ratio CARL (Carlsmed Inc)|RXST (rxsight.com) - Market Value to Book Value|Market Value to Book Value Ratio ClearPoint Neuro CLPT|STXS - Market Cap to Net Assets Ratio|NeuroStar - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Sight Sciences Inc|OBIO: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ANIK|NSPR (InspireMD) - Market Capitalization to Book Value Ratio|Jin Medical International Ltd (ZJYL) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio VANI|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.